Literature DB >> 28789394

Hereditary diffuse gastric cancer in two families: A case report.

Irene Feroce1, Davide Serrano1, Roberto Biffi2, Bruno Andreoni3, Viviana Galimberti4, Angelica Sonzogni5, Luca Bottiglieri5, Edoardo Botteri6, Cristina Trovato7, Monica Marabelli8, Guglielmina Nadia Ranzani8, Bernardo Bonanni1.   

Abstract

Hereditary diffuse gastric cancer (HDGC) is associated with E-cadherin 1 (CDH1) germline mutations. In the present study, two unusual HDGC cases are described. Case 1 was a female with no family history of gastric cancer who developed Hodgkin's lymphoma at 19 years of age, and DGC at 32 years of age. Due to her young age (32 years), the patient was examined for CDH1 abnormalities and a deleterious mutation was identified. Her father and younger sister were identified to be carriers of the mutation. Case 2 was a 36-year-old female diagnosed with lobular breast cancer (LBC); her mother had LBC, and her grandmother had LBC and DGC. The molecular test was wild-type for breast cancer susceptibility genes 1 and 2; however, a large deletion in CDH1 was identified. At prophylactic gastrectomy, early DGC was identified. Early onset of DGC and LBC justifies testing for CDH1. A better knowledge of tumor natural history in carrier subjects is important to aid genetic counseling, in order to assess the surveillance time required prior to carrying out prophylactic surgery.

Entities:  

Keywords:  cadherin 1; diffuse gastric cancer; genetic counseling; lobular breast cancer; signet ring gastric cancer

Year:  2017        PMID: 28789394      PMCID: PMC5529793          DOI: 10.3892/ol.2017.6354

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  22 in total

1.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION.

Authors:  P LAUREN
Journal:  Acta Pathol Microbiol Scand       Date:  1965

2.  Association of family history with cancer recurrence and survival in patients with gastric cancer.

Authors:  Mi Ah Han; Myueng Guen Oh; Il Ju Choi; Sook Ryun Park; Keun Won Ryu; Byung-Ho Nam; Soo-Jeong Cho; Chan Gyoo Kim; Jun Ho Lee; Young-Woo Kim
Journal:  J Clin Oncol       Date:  2012-01-23       Impact factor: 44.544

3.  Family history and the risk of stomach cancer death in Japan: differences by age and gender.

Authors:  Hiroshi Yatsuya; Hideaki Toyoshima; Tetsuya Mizoue; Takaaki Kondo; Koji Tamakoshi; Yoko Hori; Noritaka Tokui; Yoshiharu Hoshiyama; Shogo Kikuchi; Kiyomi Sakata; Norihiko Hayakawa; Akiko Tamakoshi; Yoshiyuki Ohno; Takesumi Yoshimura
Journal:  Int J Cancer       Date:  2002-02-10       Impact factor: 7.396

4.  The E-cadherin gene is silenced by CpG methylation in human oral squamous cell carcinomas.

Authors:  S Nakayama; A Sasaki; H Mese; R E Alcalde; T Tsuji; T Matsumura
Journal:  Int J Cancer       Date:  2001-09-01       Impact factor: 7.396

5.  Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.

Authors:  Rachel S van der Post; Ingrid P Vogelaar; Peggy Manders; Lizet E van der Kolk; Annemieke Cats; Liselotte P van Hest; Rolf Sijmons; Cora M Aalfs; Margreet G E M Ausems; Encarna B Gómez García; Anja Wagner; Frederik J Hes; Neeltje Arts; Arjen R Mensenkamp; J Han van Krieken; Nicoline Hoogerbrugge; Marjolijn J L Ligtenberg
Journal:  Gastroenterology       Date:  2015-06-11       Impact factor: 22.682

6.  Helicobacter, Inflammation, and Gastric Cancer.

Authors:  Antonia R Sepulveda
Journal:  Curr Pathobiol Rep       Date:  2013-03

7.  E-cadherin deficiency initiates gastric signet-ring cell carcinoma in mice and man.

Authors:  Bostjan Humar; Vanessa Blair; Amanda Charlton; Helen More; Iain Martin; Parry Guilford
Journal:  Cancer Res       Date:  2009-02-17       Impact factor: 12.701

8.  Complementary molecular approaches reveal heterogeneous CDH1 germline defects in Italian patients with hereditary diffuse gastric cancer (HDGC) syndrome.

Authors:  Valeria Molinaro; Valeria Pensotti; Monica Marabelli; Irene Feroce; Monica Barile; Simonetta Pozzi; Luigi Laghi; Davide Serrano; Loris Bernard; Bernardo Bonanni; Guglielmina Nadia Ranzani
Journal:  Genes Chromosomes Cancer       Date:  2014-02-03       Impact factor: 5.006

9.  Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.

Authors:  Pardeep Kaurah; Andrée MacMillan; Niki Boyd; Janine Senz; Alessandro De Luca; Nicki Chun; Gianpaolo Suriano; Sonya Zaor; Lori Van Manen; Cathy Gilpin; Sarah Nikkel; Mary Connolly-Wilson; Scott Weissman; Wendy S Rubinstein; Courtney Sebold; Robert Greenstein; Jennifer Stroop; Dwight Yim; Benoit Panzini; Wendy McKinnon; Marc Greenblatt; Debrah Wirtzfeld; Daniel Fontaine; Daniel Coit; Sam Yoon; Daniel Chung; Gregory Lauwers; Antonio Pizzuti; Carlos Vaccaro; Maria Ana Redal; Carla Oliveira; Marc Tischkowitz; Sylviane Olschwang; Steven Gallinger; Henry Lynch; Jane Green; James Ford; Paul Pharoah; Bridget Fernandez; David Huntsman
Journal:  JAMA       Date:  2007-06-03       Impact factor: 56.272

10.  Turmeric (curcumin) remedies gastroprotective action.

Authors:  Santosh Kumar Yadav; Ajit Kumar Sah; Rajesh Kumar Jha; Phoolgen Sah; Dev Kumar Shah
Journal:  Pharmacogn Rev       Date:  2013-01
View more
  5 in total

1.  Germline mutations in hereditary diffuse gastric cancer.

Authors:  Hao Zhang; Mengmeng Feng; Yi Feng; Zhaode Bu; Ziyu Li; Shuqin Jia; Jiafu Ji
Journal:  Chin J Cancer Res       Date:  2018-02       Impact factor: 5.087

Review 2.  Molecular biology as a tool for the treatment of cancer.

Authors:  Carla de Castro Sant' Anna; Alberto Gomes Ferreira Junior; Paulo Soares; Fabricio Tuji; Eric Paschoal; Luiz Cláudio Chaves; Rommel Rodriguez Burbano
Journal:  Clin Exp Med       Date:  2018-07-13       Impact factor: 3.984

Review 3.  Hereditary diffuse gastric cancer: how to look for and how to manage it.

Authors:  Karol Polom; Daniele Marrelli; Alessia D'Ignazio; Franco Roviello
Journal:  Updates Surg       Date:  2018-06-04

Review 4.  Diffuse Gastric Cancer: A Summary of Analogous Contributing Factors for Its Molecular Pathogenicity.

Authors:  Shamshul Ansari; Boldbaatar Gantuya; Vo Phuoc Tuan; Yoshio Yamaoka
Journal:  Int J Mol Sci       Date:  2018-08-16       Impact factor: 5.923

5.  CDH1 Mutation Distribution and Type Suggests Genetic Differences between the Etiology of Orofacial Clefting and Gastric Cancer.

Authors:  Arthavan Selvanathan; Cheng Yee Nixon; Ying Zhu; Luigi Scietti; Federico Forneris; Lina M Moreno Uribe; Andrew C Lidral; Peter A Jezewski; John B Mulliken; Jeffrey C Murray; Michael F Buckley; Timothy C Cox; Tony Roscioli
Journal:  Genes (Basel)       Date:  2020-04-03       Impact factor: 4.096

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.